| Followers | 1106 |
| Posts | 279775 |
| Boards Moderated | 10 |
| Alias Born | 03/18/2011 |
Thursday, April 26, 2012 8:34:13 AM
~ Thursday! $INCY ~ Q1 Earnings posted, pending or coming soon! In Charts and Links Below!
~ $INCY ~ Earnings expected on Thursday *
Want more like this? Search Keyword: MACMONEY >>> http://tinyurl.com/MACMONEY <<<
One or more of many earnings sites has alerted this security has or will be posting earnings on or around the day of this message.
http://stockcharts.com/h-sc/ui?s=INCY&p=D&b=3&g=0&id=p88783918276&a=237480049
http://stockcharts.com/h-sc/ui?s=INCY&p=W&b=3&g=0&id=p54550695994
~ Google Finance: http://www.google.com/finance?q=INCY
~ Google Fin Options: hhttp://www.google.com/finance/option_chain?q=INCY#
~ Yahoo! Finance ~ Stats: http://finance.yahoo.com/q/ks?s=INCY+Key+Statistics
~ Yahoo! Finance ~ Profile: http://finance.yahoo.com/q/pr?s=INCY
Finviz: http://finviz.com/quote.ashx?t=INCY
~ BusyStock: http://busystock.com/i.php?s=INCY&v=2
<<<<<< http://www.earningswhispers.com/stocks.asp?symbol=INCY >>>>>>
http://investorshub.advfn.com/boards/post_prvt.aspx?user=251916
*If the earnings date is in error please ignore error. I do my best.
~ $INCY ~ Earnings expected on Thursday *
Want more like this? Search Keyword: MACMONEY >>> http://tinyurl.com/MACMONEY <<<
One or more of many earnings sites has alerted this security has or will be posting earnings on or around the day of this message.
http://stockcharts.com/h-sc/ui?s=INCY&p=D&b=3&g=0&id=p88783918276&a=237480049
http://stockcharts.com/h-sc/ui?s=INCY&p=W&b=3&g=0&id=p54550695994
~ Google Finance: http://www.google.com/finance?q=INCY
~ Google Fin Options: hhttp://www.google.com/finance/option_chain?q=INCY#
~ Yahoo! Finance ~ Stats: http://finance.yahoo.com/q/ks?s=INCY+Key+Statistics
~ Yahoo! Finance ~ Profile: http://finance.yahoo.com/q/pr?s=INCY
Finviz: http://finviz.com/quote.ashx?t=INCY
~ BusyStock: http://busystock.com/i.php?s=INCY&v=2
<<<<<< http://www.earningswhispers.com/stocks.asp?symbol=INCY >>>>>>
http://investorshub.advfn.com/boards/post_prvt.aspx?user=251916
*If the earnings date is in error please ignore error. I do my best.
My stuff http://investorshub.advfn.com/boards/read_msg.aspx?message_id=64797507
Never, invest with money you need to survive. Diversify, patience, set tight stops. $20 or less in commission fees is almost always cheaper than a 5-40%+ drop in share value.
Recent INCY News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/21/2026 08:02:16 PM
- Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 05/20/2026 08:02:11 PM
- Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 05/20/2026 08:01:39 PM
- Incyte and Genesis Expand Molecular AI Collaboration to Accelerate Drug Discovery • Business Wire • 05/20/2026 12:00:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/19/2026 08:21:17 PM
- Incyte and Edison Scientific Announce Strategic Collaboration to Employ the Kosmos AI Platform for Research and Development • Business Wire • 05/19/2026 12:00:00 PM
- Incyte annonce que plus de 20 résumés ont été retenus en vue d'une présentation lors du Congrès 2026 de l'Association européenne d'hématologie (EHA) • Business Wire • 05/13/2026 04:52:00 PM
- Incyte gibt bekannt, dass mehr als 20 Abstrakte für die Präsentation auf dem Kongress der European Hematology Association (EHA) 2026 angenommen wurden • Business Wire • 05/13/2026 04:51:00 PM
- Incyte Announces More Than 20 Abstracts Accepted for Presentation at the European Hematology Association (EHA) 2026 Congress • Business Wire • 05/12/2026 01:30:00 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 05/11/2026 08:59:57 PM
- Incyte annonce les données à long terme sur 24 semaines de l'essai de phase 3 TRuE-AD4 sur la crème Opzelura® (ruxolitinib) chez les adultes atteints de dermatite atopique modérée • Business Wire • 05/07/2026 11:01:00 PM
- Incyte gibt Langzeitdaten nach 24 Wochen aus der Phase-3-Studie TRuE-AD4 zur Opzelura® (Ruxolitinib)-Creme bei Erwachsenen mit mittelschwerer atopischer Dermatitis bekannt • Business Wire • 05/07/2026 11:01:00 PM
- Incyte Announces 24-Week Long-Term Data from Phase 3 TRuE-AD4 Trial of Opzelura® (ruxolitinib) Cream in Adults with Moderate Atopic Dermatitis • Business Wire • 05/07/2026 12:50:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/06/2026 08:34:55 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/06/2026 08:34:13 PM
- Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 05/06/2026 08:30:00 PM
- Incyte annonce l’autorisation par la FDA des comprimés à libération prolongée Jakafi XR™ (ruxolitinib) pour le traitement de la myélofibrose, de la polycythémie vraie et de la maladie du greffon contre l’hôte • Business Wire • 05/03/2026 01:50:00 PM
- Incyte gibt die FDA-Zulassung von Jakafi XR™ (Ruxolitinib) Retardtabletten zur Behandlung von Myelofibrose, Polycythaemia vera und Graft-versus-Host-Erkrankung bekannt • Business Wire • 05/03/2026 01:50:00 PM
- Incyte Announces FDA Approval of Jakafi XR™ (ruxolitinib) Extended-Release Tablets for the Treatment of Myelofibrosis, Polycythemia Vera and Graft-Versus-Host Disease • Business Wire • 05/01/2026 09:28:00 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 04/30/2026 02:30:26 PM
- Incyte to Present at Upcoming Investor Conferences • Business Wire • 04/29/2026 12:00:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/28/2026 08:26:36 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/28/2026 08:25:54 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/28/2026 08:02:46 PM
